June 2018
Features
Clinical Conversation Corticosteroids for DME: Lessons from Protocol U
Our expert panel parses how the DRCRnet trial informs how they use of corticosteroids in diabetic macular edema. Part 2 of 2.
Retina Standouts from ARVO 2018 Novel Treatments for RP, CSC and More
Promising results of topical treatment for macular holes, non-drug anesthesia for IVT and RRD repair without prone positioning.
Quality of Life and Vitreoretinal Interventions
Payers want to know how much that medical intervention improves a patient’s life. There’s a way to measure that.
SCORE2 Lessons for Treatment Of ME due to CRVO or HRVO
This study provides Level 1 evidence that bevacizumab and aflibercept have similar visual acuity outcomes in patients with macular edema associated with central or hemi-retinal vein occlusion.
ERM Pathogenesis: Three Theories Suggest Defects of Vitreous and ILM
Controversy surrounds the causes of idiopathic epiretinal membrane, but the dominant theories are not necessarily mutually exclusive.
Departments
Clinical Trial Closeup
A Smaller, Faster Anti-VEGF Therapy
How brolucizumab may extend dosing out to 12 weeks.
Coding Commentary
Yet Another Medicare Audit Process
Here’s what you can expect from and how you can prepare for a Targeted Probe and Education review.
Editor's Page
News
Retina Rounds
Retinal Pathology with Glaucoma
Is macular schisis and serous retinal detachment a coincidence or contribution from the optic nerve head?
Surgical Pearl Video
Modified ILM Flap for Refractory Holes
A modified approach to internal limiting membrane flaps in eyes with a previous ILM peel.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
